Prostate Cancer - Results from #24720

Denosumab for the treatment of cancer therapy-induced bone loss and prevention of skeletal-related events in patients with solid tumors - Abstract September 25, 2012

Cost-effectiveness analysis of stereotactic body radiation therapy versus intensity-modulated radiation therapy: An emerging initial radiation treatment option for organ-confined prostate cancer - Abstract September 25, 2012

Docetaxel plus prednisone versus mitoxantrone plus prednisone as first-line chemotherapy for metastatic hormone-refractory prostate cancer: Long-term effects and safety - Abstract September 25, 2012

African American prostate cancer survivors' treatment decision-making and quality of life - Abstract September 24, 2012

Transrectal biopsy scheme can predict incorrect histological grading in prostate cancer - Abstract September 24, 2012

Completeness of prostate cancer staging in the Danish Cancer Registry, 2004-2009 - Abstract September 24, 2012

Docetaxel in combination with estramustine and prednisolone for castration-resistant prostate cancer - Abstract September 24, 2012

Family history of prostate cancer in a Black population - Abstract September 24, 2012

Effects of androgen deprivation therapy and bisphosphonate treatment on bone in patients with metastatic castration resistant prostate cancer: Results from the University of Washington rapid autopsy series - Abstract September 24, 2012

Validity of the recorded codes of gonadotropin-releasing hormone agonist treatment and orchiectomies in the Danish National Patient Registry - Abstract September 24, 2012

Diabetic nephropathy is associated with prostate-specific antigen levels in type 2 diabetes mellitus - Abstract September 24, 2012

The impact of prostate biopsy on urinary symptoms, erectile function, and anxiety - Abstract September 21, 2012

20-Year survival after radical prostatectomy as initial treatment for cT3 prostate cancer - Abstract September 21, 2012

Comparative cost-effectiveness of stereotactic body radiation therapy versus intensity-modulated and proton radiation therapy for localized prostate cancer - Abstract September 21, 2012

Review of hypofractionated radiotherapy for prostate cancer - Abstract September 21, 2012

Sequencing of cabazitaxel in metastatic castrate-resistant prostate cancer: A case report - Abstract September 21, 2012

A comparison of virtual touch tissue quantification and digital rectal examination for discrimination between prostate cancer and benign prostatic hyperplasia - Abstract September 21, 2012

Treatment-induced bone loss and fractures in cancer patients undergoing hormone ablation therapy: Efficacy and safety of denosumab - Abstract September 21, 2012

Quality of life after intensity-modulated radiotherapy for prostate cancer with a hydrogel spacer: Matched-pair analysis - Abstract September 21, 2012

HPV persistence and its oncogenic role in prostate tumors - Abstract September 21, 2012

Page 1237 of 1435